United States · FDA National Drug Code directory
Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-8517_62c43ba0-3b1e-4bf2-b009-fc5b8f8b7add
- Product NDC
- 68788-8517
- Form
- TABLET
- Composition / generic term
- Hydrochlorothiazide
- Labeler
- Preferred Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230901
- Source listing expiry
- 20271231
Source-listed ingredients
- HYDROCHLOROTHIAZIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (68788-8517-0) · 68788-8517-0
- 15 TABLET in 1 BOTTLE (68788-8517-1) · 68788-8517-1
- 30 TABLET in 1 BOTTLE (68788-8517-3) · 68788-8517-3
- 60 TABLET in 1 BOTTLE (68788-8517-6) · 68788-8517-6
- 90 TABLET in 1 BOTTLE (68788-8517-9) · 68788-8517-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →